Hepatitis C-Induced Renal Disease in Patients with AIDS: An Emergent Problem

被引:0
|
作者
Praga, Manuel [1 ]
Gutierrez Solis, Elena [1 ]
Morales, Enrique [1 ]
机构
[1] Univ Complutense Madrid, Hosp 12 Octubre, Serv Nefrol, Nephrol Div,Hosp Univ 12 Octubre,Inst Invest, ES-28041 Madrid, Spain
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-ASSOCIATED NEPHROPATHY; IMMUNE-COMPLEX GLOMERULONEPHRITIS; ACTIVE ANTIRETROVIRAL THERAPY; FIBROSIS PROGRESSION; INFECTION; COINFECTION; EPIDEMIOLOGY; PREVALENCE; SURVIVAL;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cryoglobulinemic membranoproliferative glomerulonephritis (MPGN) is the more characteristic renal disease associated with hepatitis C virus (HCV) infection. Patients infected with human immunodeficiency virus (HIV) can present, in addition to HIV-associated nephropathy, different types of immune complex glomerulonephritis, including MPGN, IgA nephropathy, non-collapsing focal segmental glomerulosclerosis, membranous nephropathy and lupus-like glomerulonephritis. On the other hand, the incidence of hypertensive nephrosclerosis, diabetic nephropathy and decreased renal function similar to that of elderly patients is increasingly recognized among HIV-infected patients. In spite of the fact that HCV coinfection in HIV patients is a very common problem, affecting approximately 30% of HIV-infected patients, information about the role of HCV in renal diseases of HIV-infected patients is scant. A large proportion of HIV patients with glomerular diseases are coinfected with HCV, and the latter is likely the responsible agent in those cases of cryoglobulinemic MPGN reported in HIV-infected patients. Participation of HCV in other types of HIV-related glomerular diseases is uncertain. Patient and renal survival in glomerular diseases of patients coinfected with HIV and HCV is very poor, but some studies suggest that antiretroviral therapy might change this dismal prognosis. Information about the effect of specific anti-VHC therapy or immunosuppressive agents in these patients is very limited. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:24 / 34
页数:11
相关论文
共 50 条
  • [31] Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents
    Lim, E. J.
    Chin, R.
    Nachbur, U.
    Silke, J.
    Jia, Z.
    Angus, P. W.
    Torresi, J.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (09) : 730 - 743
  • [32] Metabolic Phenotyping for Enhanced Mechanistic Stratification of Chronic Hepatitis C-Induced Liver Fibrosis
    Sands, Caroline J.
    Guha, Indra N.
    Kyriakides, Michael
    Wright, Mark
    Beckonert, Olaf
    Holmes, Elaine
    Rosenberg, William M.
    Coen, Muireann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (01): : 159 - 169
  • [33] Role of haemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease
    Martín, J
    de Sequera, P
    Quiroga, JA
    Rico, M
    Fernández, M
    Arocena, C
    Caramelo, C
    Carreño, V
    CYTOKINE, 2000, 12 (08) : 1248 - 1252
  • [34] Immune Response to Extracellular Matrix Collagen in Chronic Hepatitis C-Induced Liver Fibrosis
    Borg, Brian B.
    Seetharam, Anil
    Subramanian, Vijay
    Basha, Haseeb Ilias
    Lisker-Melman, Mauricio
    Korenblat, Kevin
    Anderson, Christopher D.
    Shenoy, Surendra
    Chapman, William C.
    Crippin, Jeffrey S.
    Mohanakumar, Thalachallour
    LIVER TRANSPLANTATION, 2011, 17 (07) : 814 - 823
  • [35] Detection and characterization of focal liver lesions with contrast-enhanced ultrasonography in patients with hepatitis C-induced liver cirrhosis
    Rahbin, N.
    Siosteen, A. -K.
    Elvin, A.
    Blomqvist, L.
    Hagen, K.
    Hultcrantz, R.
    Aleman, S.
    ACTA RADIOLOGICA, 2008, 49 (03) : 251 - 257
  • [36] Projected Age-Based Prevalence and Management Cost of Chronic Hepatitis C-Induced Advanced Liver Disease in the United States
    Deniz, Baris
    Velez, Fulton
    Pyenson, Bruce
    Iwasaki, Kosuke
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S399 - S399
  • [37] Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency
    Bruchfeld, A
    Lindahl, K
    Ståhle, L
    Söderberg, M
    Schvarcz, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (08) : 1573 - 1580
  • [38] Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease?
    Perez, Renata M.
    Ferreira, Adalgisa S. P.
    Medina-Pestana, Jose O.
    Cendoroglo-Neto, Miguel
    Lanzoni, Valeria P.
    Silva, Antonio Eduardo B.
    Ferraz, Maria Lucia G.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (05) : 444 - 448
  • [39] Antibodies to hepatitis C virus in patients with chronic renal disease in Sri Lanka
    Fernando, S
    Sheriff, FMHR
    Vitarana, UT
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (08) : 3087 - 3090
  • [40] Hepatitis C infection in patients on chronic renal dialysis: A histologically benign disease
    Cheruvattath, R
    Neuschwander-Tetri, B
    Garvin, P
    Brunt, E
    Luxon, B
    GASTROENTEROLOGY, 2002, 123 (01) : 50 - 50